Evidence map›Paper›PMID 34649274›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2022

Volume Reduction of the Dorsal Lateral Prefrontal Cortex Prior to the Onset of Frank Psychosis in Individuals with an At-Risk Mental State.

Yoichiro Takayanagi, Sue Kulason, Daiki Sasabayashi, Tsutomu Takahashi, Naoyuki Katagiri, Atsushi Sakuma, Noriyuki Ohmuro, Masahiro Katsura, Shimako Nishiyama, Mikio Kido and 6 more

Open access · greenAbstract read
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Yoichiro TakayanagiDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama 9300194, Japan.
Sue KulasonCenter for Imaging Science and Institute for Computational Medicine, Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21211, USA.
Daiki SasabayashiDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama 9300194, Japan.
Tsutomu TakahashiDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama 9300194, Japan.
Naoyuki KatagiriDepartment of Neuropsychiatry, Toho University School of Medicine, Tokyo 1438541, Japan.
Atsushi SakumaDepartment of Psychiatry, Tohoku University Hospital, Sendai, Miyagi 9808574, Japan.
Noriyuki OhmuroDepartment of Psychiatry, Tohoku University Hospital, Sendai, Miyagi 9808574, Japan.
Masahiro KatsuraDepartment of Psychiatry, Tohoku University Hospital, Sendai, Miyagi 9808574, Japan.
Shimako NishiyamaDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama 9300194, Japan.
Mikio KidoDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama 9300194, Japan.
Atsushi FuruichiDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama 9300194, Japan.
Kyo NoguchiDepartment of Radiology, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama 9300194, Japan.
Kazunori MatsumotoDepartment of Psychiatry, Tohoku University Hospital, Sendai, Miyagi 9808574, Japan.
Masafumi MizunoDepartment of Neuropsychiatry, Toho University School of Medicine, Tokyo 1438541, Japan.
J Tilak RatnanatherCenter for Imaging Science and Institute for Computational Medicine, Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21211, USA.
Michio SuzukiDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama 9300194, Japan.
University of Toyama · JPTohoku University Hospital · JPJohns Hopkins University · USToho University · JPOsaki Citizen Hospital · JP

Funding

TR&D 4: Algorithms for functional and anatomical brain analysisP41EB015909 · NIBIB · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI VAN ZIJL, PETER CM · 2012 to 2020
$13.1M
NIBIB NIH HHS P41 EB015909
6 · The paper itself

Abstract

Although some individuals with at-risk mental states (ARMS) develop overt psychosis, surrogate markers which can reliably predict a future onset of psychosis are not well established. The dorsal lateral prefrontal cortex (DLPFC) is thought to be involved in psychotic disorders such as schizophrenia. In this study, 73 ARMS patients and 74 healthy controls underwent 1.5-T 3D magnetic resonance imaging scans at three sites. Using labeled cortical distance mapping, cortical thickness, gray matter (GM) volume, and surface area of DLPFC were estimated. These measures were compared across the diagnostic groups. We also evaluated cognitive function among 36 ARMS subjects to clarify the relationships between the DLPFC morphology and cognitive performance. The GM volume of the right DLPFC was significantly reduced in ARMS subjects who later developed frank psychosis (ARMS-P) relative to those who did not (P = 0.042). There was a positive relationship between the right DLPFC volume and the duration prior to the onset of frank psychosis in ARMS-P subjects (r = 0.58, P = 0.018). Our data may suggest that GM reduction of the DLPFC might be a potential marker of future onset of psychosis in individuals with ARMS.

Indexed as

Psychotic DisordersSchizophreniaGray MatterHumansMagnetic Resonance ImagingPrefrontal Cortexat-risk mental statedorsal lateral prefrontal cortexmagnetic resonance imagingpsychosisschizophrenia

Identifiers

PMID34649274
PMCPMC9113353
OpenAlexW3206203661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.